Country development and manuscript selection bias: a review of published studies by Yousefi-Nooraie, Reza et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Correspondence
Country development and manuscript selection bias: a review of 
published studies
Reza Yousefi-Nooraie*1,2, Behnam Shakiba2 and Soroush Mortaz-Hejri1
Address: 1Center of Evidence Based Medicine, Tehran University of Medical Sciences, Shariati hospital, Kargar shomali Ave, Tehran, Iran and 
2Students' Scientific Research Center, Third floor, Faculty of medicine, Tehran University of Medical Sciences, Tehran, Iran
Email: Reza Yousefi-Nooraie* - ryousefi@razi.tums.ac.ir; Behnam Shakiba - b_shakiba@razi.tums.ac.ir; Soroush Mortaz-
Hejri - s_mortazhejri@razi.tums.ac.ir
* Corresponding author    
Abstract
Background: Manuscript selection bias is the selective publication of manuscripts based on study
characteristics other than quality indicators. One reason may be a perceived editorial bias against
the researches from less-developed world. We aimed to compare the methodological quality and
statistical appeal of trials from countries with different development status and to determine their
association with the journal impact factors and language of publication.
Methods: Selection criteria: Based on the World Bank income criteria countries were divided into
four groups. All records of clinical trials conducted in each income group during 1993 and 2003
were included if they contained abstract and study sample size. Data sources: Cochrane Controlled
Trials Register was searched and 50 articles selected from each income group using a systematic
random sampling method in years 1993 and 2003 separately. Data extraction: Data were extracted
by two reviewers on the language of publication, use of randomization, blinding, intention to treat
analysis, study sample size and statistical significance. Disagreement was dealt with by consensus.
Journal impact factors were obtained from the institute for scientific information.
Results: Four hundred records were explored. Country income had an inverse linear association
with the presence of randomization (chi2 for trend = 5.6, p = 0.02) and a direct association with
the use of blinding (chi2 for trend = 6.9, p = 0.008); although in low income countries the
probability of blinding was increased from 36% in 1993 to 46% in 2003. In 1993 the results of 68%
of high income trials and 64.7% of other groups were statistically significant; but in 2003 they were
66% and 82% respectively. Study sample size and income were the only significant predictors of
journal impact factor.
Conclusion: The impact of country development on manuscript selection bias is considerable and
may be increasing over time. It seems that one reason may be more stringent implementation of
the guidelines for improving the reporting quality of trials on developing world researchers.
Another reason may be the presumptions of the researchers from developing world about the
editorial bias against their nationality.
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Background
Publication bias is defined as "the tendency to publish
research results based on the strength and direction of
findings"[1]. It is well documented that studies with non-
significant or negative results are substantially less likely
to be submitted for publication[2,3]. In addition, the pro-
portion of published articles from low income countries is
lower than more developed nations in many research
fields, including psychiatry[4], cardiovascular disease[5]
and epidemiology[6]. A recent survey concluded that
researchers from less-developed countries believe that one
likely reason is a substantial editorial bias against their
work[7]. The tendency of editors to publish research
results based on study characteristics other than quality
indicators is called generally manuscript selection bias in
the current study, which is broader than the publication
bias definition. The purpose of present study was to com-
pare the methodological quality and statistical appeal of
published trials from countries with different develop-
mental status and to determine their association with the
journal impact factor and language of publication.
Methods
Selection criteria
Based on the World Bank income criteria countries were
divided into low, lower-middle, upper-middle and high
income groups[8]. All records of clinical trials conducted
in each income group during 1993 and 2003 were
included if they contained abstract and the number of
study participants (study sample size) could be calculated
from the abstract content.
Search strategy
Cochrane Central Register of Controlled Trials (2005,
issue1) was searched for all trials including the names of
countries in each income group in the Institution field of
the records. Fifty articles in each income group were
selected using a systematic random sampling method in
years 1993 and 2003 separately, which comprised of the
total of 400 citations. All the citations identified by the
above searches were screened and animal studies, non
interventional studies or conference abstracts were
excluded by consensus; then the sampling was performed
once more to replace the excluded citations.
Data extraction
Data were extracted by two reviewers on the language of
publication, use of randomization, blinding (masking,
placebo or sham), intent(ion) to treat analysis, study sam-
ple size and statistical significance. An article was classi-
fied as non-English if it was described in the bibliographic
details. Quality assessment was restricted to the statement
of randomization, blinding and intention to treat analy-
sis. The results of a trial was called significant when there
was at least a p < 0.05, the 95% confidence interval
excluded no effect, or the statistical significance was stated
qualitatively in the results section for any finding of the
study. Disagreement was dealt with by discussion. Infor-
mation on journal impact factor was obtained from the
1994 and 2003 editions of the Science Citation Index
Journal Citation Reports.
Statistical analysis
The Chi square for trend test was applied to the cross-tab
of randomization (or blinding, significance) and country
income to assess the differences between levels of country
income.
Forward stepwise linear regression was performed to
model the relation of country income to journal impact
factor. We included the following potential confounders
as covariates: language of publication, study sample size,
randomization, blinding, statistical significance and pub-
lication year.
As the journal impact factor was not normally distributed,
we performed logarithmic transformation. We dichot-
omized the country income (High income = 1, others =
0), publication year (2003 = 1, 1993 = 0), language of
publication (English = 1, others = 0), use of randomiza-
tion, use of blinding and statistical significance. All analy-
ses were undertaken in SPSS version 11.5 (SPSS, Inc.,
Chicago, IL). A p value of less than 0.01 was considered
statistically significant.
Results
Four hundred records were explored. There were
377(94.3%) English language articles. According to the
title, abstract or keywords the number of Controlled clin-
ical trials which refer to the studies that compare one or
more intervention groups to one or more comparison
(control) groups was 384(96%). The number of rand-
omized controlled trials was 298(74.5%), before and after
studies was 14(3.5%) and the frequency of crossed-over
studies was 39(9.7%). Double-blind and single-blind
methods were mentioned in 141(35.3%) and 39(9.8%)
of records respectively. The loss to follow-up percent was
stated in 29 abstracts and 5 studies reported an intention-
to-treat analysis.
Country income
In 1993 the results of 68% of high income trials and
64.7% of other groups were statistically significant; but in
2003 they were 66% and 82% respectively (table 1).
Whilst in low income countries the probability of blind-
ing was increased from 36% in 1993 to 46% in 2003, in
high income countries there was about fourteen percent
decrease. Country income had a non-significant inverse
association with the presence of randomization (Chi
square for trend = 5.6, p = 0.02) and a direct significantBMC Medical Research Methodology 2006, 6:37 http://www.biomedcentral.com/1471-2288/6/37
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association with the use of blinding (Chi square for trend
= 6.9, p = 0.008). As shown in table 2 in 1993 the articles
from high income countries had an odds ratio of 1.17 for
having statistically significant results compared with the
other countries, after adjustment for the language of pub-
lication. The odds ratio decreased to 0.41 in the year 2003.
There were 2 studies in high-middle income group and 3
in low-middle income group reported an intention to
treat analysis.
Journal impact factor
In forward stepwise linear regression model, fitted on the
log impact factor the country income, the language of
publication, study sample size and the publication year
were independent predictors of journal impact factor
which remained in the model (table 3). The final model
accounted for 14.7% of the variance in journal impact fac-
tor and was statistically significant (F = 12.2, p < .0001).
Discussion and conclusion
The frequencies of blinding and statistical appealing indi-
cators in the published articles from low income nations
have increased more than developed countries during the
past ten years and the presence of randomization had a
negative association with country development in both
occasions. On the one hand, this finding may be due to an
enhancement of exclusive and biased use of critical
appraisal checklists by the editors of western medical jour-
nals. On the other hand, it may refer to the developing
world authors, who might be more keen to selectively
report the studies that are larger, have less serious limita-
tions, and containing positive and significant findings in
international english language journals, because of the
presumption that editors and reviewers are biased against
their nationality[9,10].
The poorer countries are underrepresented both on the
editorial boards and in the pages of medical journals,
which stated as a systematic bias against the diseases of
poverty [11].
Some aspects of this bias is demonstrated in the studies,
that the majority of the editorial board members of inter-
national medical journals come from nations with a high
human development index [12,13] and the studies enroll-
ing some participants from the United States are more
likely to be published[14]. In our study the effect of coun-
try development on the odds of the statistical significance
of published studies was considerable after adjustment for
the language.
We didn't find a significant relationship between method-
ological quality indicators of the research and the impact
factor of the medical journal that cited it. Conversely,
study sample size and country income were more impor-
Table 1: The frequency of randomized studies, use of blinding and statistical significance among different income groups in the 
years1993 and 2003 (numbers in the parentheses represent the 95% CIs of the absolute change)
Low Lower-middle Upper-middle High
Randomized studies:
1993 38/50(76%) 36/50(72%) 34/50(68%) 31/50(62%)
2003 44/50(88%) 38/50(76%) 39/50(78%) 37/50(74%)
Absolute change (%) 12 (-2 to 27) 4(-13 to 21) 10(-7 to 27) 12(-6 to 30)
Blinded studies:
1993 18/50(36%) 23/50(46%) 25/50(50%) 30/50(60%)
2003 23/50(46%) 16/50(32%) 22/50(44%) 23/50(46%)
Absolute change (%) 10(-9 to 29) -14(-32 to 5) -6(-25 to 14) -14(-33 to 5)
Significant results:
1993 29/50(58%) 30/50(60%) 38/50(76%) 34/50(68%)
2003 40/50(80%) 41/50(82%) 42/50(84%) 33/50(66%)
Absolute change (%) 22(4 to 39) 22(5 to 39) 8(-7 to 24) -2(-20 to 16)
Table 2: The odds ratios of the presence of randomization, 
blinding and reporting significant results in the articles from high 
income countries to the reports from the other nations adjusted 
for the language of publication
Adjusted OR(95% CI)
Randomization:
1993 0.59(0.29 to 1.17)
2003 0.64(0.29 to 1.36)
Blinding:
1993 1.93(0.99 to 3.74)
2003 2.36(1.08 to 5.13)
Statistical Significance:
1993 1.17(0.58 to 2.34)
2003 0.41(0.20 to 0.85)BMC Medical Research Methodology 2006, 6:37 http://www.biomedcentral.com/1471-2288/6/37
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tant predictors of journal impact factor, despite the gener-
ally accepted belief that the journal impact factor could be
used as a measure of journal quality[15,16].
Consequently we can interpret the result as an alarm sign
that the impact of country development on the manu-
script selection bias is increasing by time. Publication bias
is a preventable problem[17] and we suggest that "Devel-
oping country bias" should be intentionally stated as an
independent factor which can contribute to biased inclu-
sion of research manuscripts for publication; Publication
bias awareness raising programs should be planned for
developing world researchers; In addition, current stand-
ards for reporting trials should be enforced more equally
on the articles from different nations [18].
We used The Cochrane Central Register of Controlled Tri-
als (CENTRAL) as the source of studies which serves as the
most comprehensive source of records related to control-
led trials. As of January 2003, CENTRAL contained just
over 350,000 citations to reports of trials and other stud-
ies potentially relevant to Cochrane Reviews. CENTRAL
includes citations to reports of controlled trials that might
not indexed in MEDLINE, EMBASE or other bibliographic
databases; citations published in many languages; and
other sources that are difficult to access[19].
Present study has several limitations. First, the main prob-
lem with our study is the lack of a denominator i.e. the
study presents no data on the total number of papers sub-
mitted only on those papers published. If only very small
numbers of papers are published then this introduces a
bias so that it is not possible to make assumptions about
the quality of papers as a whole. Second, all assessments
are done based on the data provided in title, abstract and
keywords and obviously several useful information might
be omitted. Abstracts from higher impact journals might
contain more information and therefore yield higher
quality scores than those from other types of journal. If so,
the real differences between low and high income coun-
tries may be more than what is reported in our study. Poor
(or even fraudulent) documentation and adoption of
CONSORT statement from journals may affect the results.
Another important constraint of relying on the abstract is
that the failure to report a feature, e.g. blinding in the
abstract does not necessarily equate with failure to carry it
out. Third, we limit our investigation to clinical trials and
may underestimate the real heterogeneity among different
income groups. Fourth, data extractors were not blinded
to country and journal. We reduced its effects by consider-
ing the most objective characteristics of the studies that
could be extracted by the abstracts. Fifth, the country
income has been presumed as a surrogate for develop-
mental status. Finally, all studies included in the present
study were cited in Cochrane Central Register of Control-
led Trials which serves as the most comprehensive source
of records related to controlled trials, but mainly consists
of the articles indexed in MEDLINE and EMBASE. There is
a proven language bias in these databases[20] and may
limit the external validity of our results.
Because of the above mentioned drawbacks we suggest to
interpret the results of the present study with more cau-
tion.
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